The International mRNA Health Conference (Conference Days, 8-10 November 2022) is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines.

Starting with the first emergency use authorizations of mRNA-based vaccines in 2020, followed by full approvals in late 2021 and early 2022, the past three years have been truly transformative for mRNA technology.  Many other mRNA-based vaccines and therapeutics are now in the clinic.  Thus, we have officially entered the age of mRNA medicines! 

The mRNA Health Conference provides participants an opportunity to learn more about developments in mRNA technologies through scientific presentations by some of the most esteemed experts in the field and extensive networking opportunities.  The event brings together over 850 attendees from both academic institutions and leading pharma and biotech companies.

Building on the success of our hybrid meeting in 2021 (virtual and on-site in Berlin), the 2022 conference will continue this format (virtual and on-site in Boston).  Because of expanding interest and content, this year we’re adding a third day!  If an on-site meeting is not possible due to renewed safety concerns related to COVID-19, the event will take place exclusively online. 

The registration, abstact tool and sponsorship applications for the 10^th International mRNA Health Conference will be available from mid may.

If you would like to stay updated on event details please sign up for our newsletter. 

Together with outstanding scientists and future-oriented companies we look forward to your participation!